Tumora borderline

Diagnosis. A borderline ovarian tumor can be suspected based on imaging, such as ultrasound or MRI. However, the diagnosis can only be made by microscopic assessment after surgery, which includes removal of either the mass alone or the affected ovary and fallopian tube. A microscopic example of a serous borderline tumor showing a hierarchical. Borderline tumors, as with other ovarian tumors, are difficult to detect clinically until they are advanced in size or stage. In one study, the most common presenting symptoms were abdominal pain,.. Ovarian borderline tumors have also been referred to as tumors of low malignant potential or atypical proliferative tumors; however borderline tumor is the preferred terminology

Borderline Ovarian Tumors - UChicago Medicin

In contrast to invasive epithelial ovarian cancers, borderline tumors are more likely to occur in premenopausal women and are more likely to be stage I, or confined to the ovaries at presentation. When borderline ovarian tumors are confined to the ovaries, long-term survival approaches 100% Borderline epithelial tumors are also known as atypical proliferating tumors and used to be called low malignant potential tumors. These tumors look the same as invasive epithelial ovarian cancers when seen on an ultrasound or CT scan

Borderline Ovarian Cancer: Borderline Tumor Overview

  1. operitoneal or lymph node implant
  2. Borderline ovarian tumors are a type of epithelial ovarian tumors that exhibit some characteristics of malignancy, but appear to still be early enough in their development to be treated successfully. With tumors of this kind, the usual course of treatment is to surgically remove the growth and conduct a biopsy
  3. oasa si neoplasm ovarian bilateral. Histerectomie totala, omentectomie, anexectomie. Dupa operatie pe bilet scria, simplificat: neoplasm ovarian bilateral, 15 cm si 8 cm,nou simplificat, sper ca voi cuprinde ce e important: Tumora borderline cu aspect micropapilar - ambele ovare
  4. Borderline ovarian tumours (BOTs) are a group of ovarian neoplasms described as 'semimalignant disease' for the first time by Taylor [ 1] in 1929. BOTs are characterised by higher epithelial proliferation and more variable nuclear atypia than benign lesions; however, they have not stromal invasion, in contrast to carcinomas [ 2 ]
  5. A borderline tumor, sometimes called low malignant potential (LMP) tumor, is a distinct but yet heterogeneous group of tumors defined by their histopathology as atypical epithelial proliferation without stromal invasion
  6. Borderline tumors of the ovary (also called tumors of low malignant potential) are a heterogeneous group of lesions defined histologically by atypical epithelial proliferation without stromal invasion [ 1 ]. The behavior of these tumors is distinct from low-grade ovarian carcinoma, and they are considered a distinct clinical entity
  7. Tumors of low malignant potential (i.e., borderline tumors) account for 15% of all epithelial ovarian cancers. Nearly 75% of these tumors are stage I at the time of diagnosis. These tumors must be recognized because their prognosis and treatment is clearly different from the frankly malignant invasive carcinomas

Borderline Ovarian Tumors/Tumours of Low Malignant Potentia

  1. Borderline ovarian tumours (BOTs) have been qualified as low malignant potential tumours by the FIGO since 1971 [ 1 - 4 ]. They are classified within malignant epithelial ovarian tumours, constituting 10-20% of these (Figure 1) [ 2, 5 ]
  2. Surgery is the main treatment for recurrent borderline malignancy ovarian cancer. Debulking surgery is done to remove as much of the tumour as possible. Chemotherapy with carboplatin (Paraplatin, Paraplatin AQ) or cisplatin combined with other drugs such as paclitaxel (Taxol) may be given after surgery
  3. Borderline ovarian tumors represent a heterogeneous group of noninvasive tumors of uncertain malignant potential with characteristic histology. They occur in younger women, are present at an early stage, and have a favorable prognosis, but symptomatic recurrence and death may be found as long as 20 years after therapy in some patients
  4. Borderline ovarian tumors (BOT) are defined by FIGO committee as low malignant potential tumor . BOT are rare gynecologic tumors and represent around 10% to 15% of epithelial ovarian tumors . Prognosis is good with a global 95% 5-year overall survival and 90% 10-year overall survival [3,4]. The referral treatment of BOT is surgery.

Background: This systematic review and meta-analysis aimed to investigate local recurrence (LR) rates among the three grades (benign, borderline, and malignant) of phyllodes tumors (PTs). The study also assessed various risk factors for LR. Methods: Electronic articles published between 1 January 1995 and 31 May 2018, were searched and critically appraised The World Health Organization classification groups them into benign, borderline, and malignant on the basis of proliferation and invasiveness, and borderline Brenner tumor is defined as displaying epithelial proliferation beyond that seen in benign Brenner's tumor, but lacking stromal invasion. Borderline Brenner tumors are rare Borderline personality disorder is a mental health disorder that impacts the way you think and feel about yourself and others, causing problems functioning in everyday life. It includes self-image issues, difficulty managing emotions and behavior, and a pattern of unstable relationships. With borderline personality disorder, you have an intense. borderline tumour A term used for neoplasms with many histologic criteria of malignancy, of which the future behaviour is uncertain. Segen's Medical Dictionary. © 2012 Farlex, Inc

Clinical management of borderline ovarian tumor

5. Treatment of borderline or malignant phyllodes tumours 6. Follow-up after treatment 7. Further support. 1. What is a borderline or malignant phyllodes tumour? A phyllodes tumour is a growth of cells that forms a hard lump in the breast. Phyllodes tumours can be: benign (not cancer) malignant (cancer) borderline (somewhere between benign and. Advanced stage borderline malignancy ovarian tumours. Surgery is the main treatment for advanced stage (stages 3 and 4) borderline malignancy ovarian cancer. The types of surgery are: total hysterectomy and bilateral salpingo-oophorectomy. surgical debulking (removing as much of the cancer as possible

The annual incidence of serous borderline ovarian tumors (SBOTs) or atypical proliferative serous ovarian tumors (APSOTs) in the USA is 2.5/100,000 of which 1.5/100,000 occur in white women. 40 Between 1995 and 2004 the incidence rate in Norway and Sweden has been reported as 4.8 per 100.000 women 238,239, almost double that of the USA. 41, 42 Malignant tumors are cancers that spread and metastasize. Ovarian Mucinous Borderline Tumor of Intestinal Type is a slow-growing or rapid-growing epithelial tumor. It can occur as a single cyst or multiple cysts or as a combination of cystic and solid mass. These tumors may also occur in association with some syndromes Had 2 borderline tumors removed a year ago this month. Stage 1B. I am 48, and had hyterectomy with both ovaries removed at same time. My surgeon continuously sidesteps my questions about hormone replacement. I know there are people on the list with much worse problems than I have, but I feel my menopause symptoms from the surgery have taken. Pathology Report: Ovarian serous borderline tumor. - No gross evidence of extracystic extension of tumor. Providers choice: D39.11 (Neoplasm of uncertain behavior, right ovary) My selection: C56.1 (Malignant Neoplasm of right ovary) I came to my selection by following the ICD-10-CM Index..

Low Malignant Potential Epithelial Tumor Treatmen

Tumor borderline. Como tumor borderline se denomina un tipo de cáncer de ovario de bajo potencial maligno, por lo que no puede ser encasillado ni como tumor benigno ni como maligno (de allí su denominación fronteriza, como borderline), aunque existe el peligro de que pueda convertirse en un tumor maligno However, borderline cervical cell changes are not cancer and are very common - abnormal cell changes range from borderline, mild, moderate and severe and none of these are cancer. Most of us who have or have had sex will also have had HPV, with the immune system usually getting rid of it, although for some people it can take a few years Borderline serozni cistadenomi javljaju se s učestalošću od 9 - 15% svih seroznih tumora. Njihov rast je također cističan, papilaran i u 50% egzofitičan (tipa cvjetače). U 14 - 40% razvijaju se primarno obostrano, a često se šire izvan ovarija. Prijelaz u maligni oblik procjenjuje se na oko 13% borderline tumora Borderline Brenner tumors occur in a wide range of ages from 30 to 84 years, but are more common in older patients, with more than 80% of the patients older than 50 years (34 of 42 patients with age information). 1-4,6-9 The most frequent clinical presentation of borderline Brenner tumor is abdominal fullness or abdominal mass, followed by abdominal pain and postmenopausal bleeding. 1-4. Went to surgeon at Sloans who did a CA 125 which was rising. After tests this borderline cancer was spreading and the surgeon did a complete debulking and bowel resection, she was diagnosed with Stage 3C serous Ovarian cancer and after a three year fight she passed away in 2014

Tumors of this type are not malignant and are usually treated by surgery. About 15 out of every 100 (15%) ovarian tumors are borderline tumors. They are also called tumors with low malignant potential. Borderline tumors usually affect women between 20 and 40 years old. There are two main types of borderline ovarian tumors: serous and mucinous Borderline tumors fall under ovarian epithelial tumors. They tend to develop in an exophytic growth pattern, on the surface of the ovary, without invading the underlying stroma. Papillary projections are characteristic and may be more of a feature with borderline than malignant serous cystadenocarcinoma of the ovary Brenner tumor of the ovary is a solid, abnormal growth (tumor) on the ovary. Most Brenner tumors are not cancerous (benign). About 5% of Brenner tumors are cancerous (malignant) or have a small chance of spreading beyond its original location (borderline). [1] [2] [3] These tumors most often occur in women after menopause Borderline papillary serous tumors of the ovary, also known as ovarian tumors of low malignant potential, were first described in 1929 and were designated for separate classification in the early 1970s by the World Health Organization. Like most epithelial ovarian tumors, borderline papillary tumors are derived from serous or mucinous cell types

Dr. Barbara Coulter-Smith answered. Borderline cancer: It is considered cancer, but is exactly borderline meaning it has some cellular features of overtly or typical ovarian cancer, but not all Phyllodes tumor of the male breast is an extremely rare disease, and far fewer cases of borderline phyllodes tumors than benign or malignant tumors in the male breast have been reported. We report a case of borderline phyllodes tumor in the male breast with imaging findings of the tumor and pathologic correlation The articles by Gilks et al. and Singer et al. in this issue of the Journal explore practical and conceptual aspects of great interest relating to serous tumors of the ovary: pathologic findings of prognostic importance in advanced stage serous borderline tumors (SBTs) and genetic alterations suggesting that SBTs and serous carcinomas develop through separate pathways, i.e., a dualistic model. These tumors comprise about 38% of borderline tumors and 12% of mucinous ovarian neoplasms. The clinical features associated with APMTs are similar to those for mucinous cystadenomas. The age distribution of patients with these tumors peaks in the 5th and 6th decades. APMTs are bilateral in up to 6% of cases What defines microinvasion in the ovary? Is it important or not? How do you recognize it?Study the digital slides yourself here: https://dpa-dapa.com/#/publ..

Borderline ovarian tumors are benign but relatively large tumors that are often initially mistaken as ovarian cancers. We report three cases of stage I borderline ovarian tumors having massive ascites that we (preoperatively) suspected of being advanced ovarian cancer. The three patients (35, 47, and 73 years old) reported feeling fullness of the abdomen before consulting their gynecologist Ovarian tumors of borderline malignancy are a distinct histologic and clinical entity diagnosed in up to 15% of patients presenting with an ovarian neoplasm [].Compared with frankly malignant tumors, borderline tumors have a much better prognosis and, because they are noninvasive, may be treated less radically than invasive ovarian cancer [1, 2].. Non-malignant Brain Tumors. On January 1, 2004, all cancer registrars in the United States will begin to identify and abstract benign and borderline tumors of the brain and central nervous system.. The collection of benign brain and central nervous system tumors is mandated by Public Law 107, 260, the Benign Brain Tumor Cancer Registries Amendment Act.Any central cancer registry funded by the.

Mucinous, endometrioid, and clear cell borderline tumors are morphologically borderline, but clinically benign. Given the differences in outcome between borderline and carcinoma, these tumors must be well sampled (>1 section / cm) to appropriately exclude a carcinomatous component Introduction. The first report of borderline ovarian tumors (BOTs) or low malignant potential ovarian tumors was by Taylor in 1929 (Taylor, 1929).In 1971, the International Federation of Gynecology and Obstetrics (FIGO) proposed the terms tumors of 'low malignant potential' and in 1973, the World Health Organization (WHO) (Scully, 1975) adopted the synonym 'borderline' of serous borderline ovarian tumors, and mi-cropapillary, 10% of serous borderline ovari-an tumors, types [11]. Most low-grade serous carcinomas are thought to arise from micro-papillary borderline ovarian tumors. Serous surface borderline tumor is another variant that shows polypoid excrescences that occu-py the outer surface of the ovary

Pathology Outlines - Serous borderline tumo

Endometrioid Borderline Tumor of Ovary is a slow-growing tumor that usually presents as a single mass in the ovary. The nodule is typically less than 5 cm in size (along the largest dimension), however some may grow to greater sizes. Some cases, where this ovarian tumor grew up to 40 cm, have been reported Borderline tumor Last updated July 29, 2020. A borderline tumor, sometimes called low malignant potential (LMP) tumor, is a distinct but yet heterogeneous group of tumors defined by their histopathology as atypical epithelial proliferation without stromal invasion. [1] It generally refers to such tumors in the ovary (generally specifically called borderline ovarian tumors (BOT)) but borderline. Histopathology Ovary--Borderline ovarian tumo Borderline clear cell tumors are extremely rare, and few cases have been reported in the literature. Herein, we present a case of borderline clear cell adenofibroma of the ovary in a 58-year-old woman who presented with a pelvic mass and constipation. Physical examination revealed a 10 cm solid midline pelvic mass. Computed tomography showed an 8 cm heterogeneous enhancing mass attached to the.

Behavior Code Changes. Perhaps the most important change between ICD-O-2 and ICD-O-3 involves a small number of disease entities that have changed behavior codes.. Terms Changing from Borderline to Malignant Behavior. Eleven diagnoses are changing from borderline to malignant to reflect current medical understanding about the behavior of these neoplasms. . They include all of the refractory. Patients with borderline resectable pancreatic cancer (PDAC) are often treated with chemotherapy, radiotherapy, or both before undergoing surgery, but the optimal regimen in this setting is. Phyllodes Tumors of the Breast. Phyllodes tumors (FILL-odes or full-OH-deez) can also be spelled phylloides tumors (full-OY-deez). These are rare breast tumors that start in the connective (stromal) tissue of the breast. Phyllodes tumors are most common in women in their 40s, but women of any age can have them Phyllodes tumors can grow quickly, but they do not always spread beyond the breast. Authors of a 2013 review note that 35-64% of phyllodes tumors are benign, with the rest being borderline or.

Borderline Brenner tumor of the ovary is a rare entity characterized by papillary structures with a fibro-vascular core, covered by a transitional epithelium, and by the absence of stromal infiltration. It is associated, by definition, with a benign component of Brenner tumor. We report a case of a 68-year-old woman, with a right ovarian mass, whose morphology and immuno-profile were. Phyllodes tumors of the breast are rare, accounting for less than 1% of all breast tumors. They tend to grow quickly, but they rarely spread outside the breast. Most phyllodes tumors are benign (not cancerous), some are malignant (cancerous), and some are borderline. Learn more about phyllodes tumors

Serous Borderline Ovarian Tumors/de Nictolis et al. 153 logic criteria for SBT.* Clinical data and macroscopic and follow-up information were available in 44 cases, 19 of which with peritoneal implants; these cases were selected for the study. Two to 31 hematoxylin and eo- sin-stained sections of the primary ovarian tumors an For 203 patients with stage I tumors, the peritoneal cytology was positive in 29.4% of the patients with ovarian carcinomas, 18.2% with borderline ovarian tumors, 6.1% with endometrial carcinomas.

Borderline Ovarian Tumor

Includes all primary epithelial borderline tumors and carcinomas, carcinosarcoma, malignant germ cell tumors, and malignant sex cord-stromal tumors. This protocol is NOT required for accreditation purposes for the following: Procedure . Biopsy Primary resection specimen with no residual cancer (eg, following neoadjuvant therapy) Cytologic specimen This study aimed to investigate the clinical and pathological characteristics, and the recurrence and prognostic factors of borderline ovarian tumors (BOTs). The data of 286 patients admitted to hospital and followed up for more than ten months were analyzed retrospectively to study the clinicopathological characteristics and related factors of recurrence For patients with borderline resectable disease, downstaging and downsizing the tumor becomes particularly important. Neoadjuvant treatment regimens of chemotherapy or radiation are typically administered with the hope that surgery can take place and microscopic distant metastases will be eliminated

Applies to primary borderline tumors, carcinomas, germ cell tumors, and sex-cord stromal tumors only Based on AJCC/UICC TNM, 6th edition and FIGO 2001 Annual Report OVARY: Oophorectomy, Salpingo-oophorectomy, Subtotal Oophorectomy or Removal of Tumor in Fragments, Hysterectomy with Salpingo-oophorectomy Note: Applies to ovarian primary tumor Ovarian mucinous borderline tumors are divided into two morphologic groups: endocervical-like and intestinal type, the latter comprising the majority of cases. Thirty-one endocervical-like ovarian mucinous borderline tumors (ELMBTs) were reviewed and evaluated for the presence of intraepithelial carcinoma and microinvasion Phyllodes tumors are a fibroepithelial tumor composed of an epithelial and a cellular stromal component. They may be considered benign, borderline, or malignant depending on histologic features including stromal cellularity, infiltration at the tumor's edge, and mitotic activity. All forms of phyllodes tumors are regarded as having malignant.

Prognosis. Phyllodes tumors are rare breast tumors that occur in connective breast tissue. 1  These sarcomas get their name from their leaf-shaped growth pattern ( phullon means leaf in Greek). Phyllodes tumors are fast-growing, but usually benign. Some, however, can be malignant or turn into breast cancer, as is the reality in up to one in. The Brain Tumor Epidemiology Consortium (BTEC) is a broad organization involved in global cancer registration of brain and other CNS tumors. Carol Kruchko will moderate a multi-disciplinary panel from the BTEC who will provide an overview of benign and borderline CNS tumors and present examples, such as craniopharyngioma

Treatment of Skin Disease: Comprehensive Therapeutic

Ovarian mucinous borderline tumors are traditionally divided into 2 morphologic groups: endocervical type, also known as seromucinous, and intestinal type. We present a case of stage 4B seromucinous ovarian borderline tumor with endometriosis and review the literature. At the time of writing, this is believed to be the first case of a seromucinous borderline tumor reported at such an advanced. Borderline tumours arise from the same type of cells, but their growth is much more controlled, and they are usually not able to spread. A diagnosis of borderline ovarian tumour can be confusing, because you are treated by cancer specialists, but it is not a cancer diagnosis. Most cases of ovarian cancer are found at an advanced stage (stage 3. borderline tumor definition. A 33-year-old male asked: what is the definition or description of: borderline ovarian tumor? Dr. Sewa Legha answered. 50 years experience Medical Oncology. It is low grade Canc: It is a slow growing(low grade) cancer of the ovary which is diagnosed in a small percent of cases. It does not seem to cause serious. Ovarian Mucinous Borderline Tumor of Endocervical Type is a slow-growing or rapid-growing epithelial tumor. It can occur as a single cyst or multiple cysts or as a combination of cystic and solid mass. These tumors may also occur in association with some syndromes Borderline ovarian cancer - or borderline ovarian tumours, BOT - is a confusing diagnosis. It's quite rare - only around 10% of all ovarian cancers are borderline. Borderline ovarian cancer is, essentially, grade 0 ovarian cancer. Typical ovarian cancer is graded 1, 2 or 3 depending on how aggressive it is. The cells that mak

Onkonet :: Naslovna

Objectives Since the recognition of borderline ovarian tumors (BOTs) in the 1970s, the management of this subset of epithelial ovarian tumors has presented a challenge to clinicians. The majority present at an early stage, but their diagnosis is often only made following surgery, hence the heterogeneity of surgical management. Borderline ovarian tumors are morphologically diverse, and their. Atunci cand se gasesc tumori ovariene, acestea sunt de obicei bilaterale, contin arii cu aspect de tumora borderline, au lacuri mari de mucus care diseca parenchimul si acopera suprafetele corticale. Astfel de tumori au fost denumite de multe ori pseudomyxomul ovarian (5, 12), sau carcinom ova-rian cu producere extracelulara de mucina

Mucinous borderline tumors produce large multicystic masses with smooth outer surfaces that may resemble benign mucinous cystadenomas. PMP is defined clinically on the basis of intraoperative findings as a grossly visible, localized, or generalized accumulation of mucus in the pelvis or abdomen, either lying on and attached to the peritoneal. Pancreatic cancer occurs due to uncontrolled division of abnormal cells present in the pancreas. Borderline resectable pancreatic cancer is an intermediate type of cancer between resectable and unresectable pancreatic cancer. These cancers are not confined within the pancreas and have extende Home / ovarian cancer, Patient Story, survivor story / My Borderline Ovarian Tumor Survival Story. View Larger Image; June 26, 2006, I left work early with extreme stomach and lower back pain. I tried a heating pad, I tried a bubble bath, until I finally reached a point where I knew with the amount of pain I was in, and something had to really. The cyst was thought to be benign even after the surgery. I got the pathology report last week and it is Borderline Tumor. Serous Borderline Cystic Tumor. Capsule is Intact. Grade 1/3. Location: left ovary. Size: 2.4*2.2*1.2. Tumor on external surface: negative. Tumor capsule: received with intact wall Borderline tumors tend to affect younger women than the typical ovarian cancers. These tumors grow slowly and are less life-threatening than most ovarian cancers. Malignant epithelial ovarian tumors. Cancerous epithelial tumors are called carcinomas. About 85% to 90% of malignant ovarian cancers are epithelial ovarian carcinomas

Tumora borderline - ROmedi

Introduction. Ovarian serous tumors are classified as benign (60%), borderline (15%), or malignant (25%) according to their biological nature. 1, 2 With a low malignant potential, borderline tumors histologically demonstrate mitotic activity and nuclear atypia that are intermediate to those of their clearly benign and overtly malignant counterparts, but without stromal invasion. 2, 3 The. Borderline cases can progress to overt hypothyroidism, so some say it's useful to take medication, especially if you also have a risk of heart disease; even mild hypothyroidism can lead to. Borderline resectable tumors in the pancreatic head/uncinate process are classified as having solid tumor contact with the CHA without extension to the CA, hepatic artery bifurcation allowing for safe and complete resection and reconstruction, or solid tumor contact with the SMA of ≤180°. In the pancreatic body/tail, borderline These tumors account for 15% of all epithelial ovarian cancers, and nearly 75% are diagnosed at Stage 1. These tumors are recognized as distinct from the malignant invasive carcinomas described below because their prognosis and treatment is markedly different. Borderline epithelial ovarian cancer may not cause early signs or symptoms borderline resectable tumors. Preoperative Therapy for Borderline Resectable Pancreatic Cancer There are many obvious advantages to preoperative treatment of patients with borderline resectable pancreatic cancer. 1) The ability to provide immediate systemic therapy for a disease that is systemic at diagnosis in most patients

Borderline ovarian tumours: management in the era of

A tumor within the body or tail is considered borderline resectable if there is contact ≤180° with CA or >180° of CA without involvement of aorta and with an uninvolved, intact GDA. The MDACC definition published in 2006 allows for short segment occlusion of the SMV-PV as long as a suitable vessel is available above and below the involved. Purpose Ovarian serous borderline tumors (SBT) are characterized by arborizing papillae lined by stratified epithelial cells, varying atypia, and absence of stromal invasion. Originally, these tumors have been classified as borderline because they behaved in a remarkably indolent manner, even with widespread tumor deposits called implants and the presence of lymph node involvement. The. Overview. A phyllodes tumor is a rare tumor of the breast. Phyllodes tumors grow in the connective tissue of the breast, called the stroma. This includes the tissue and ligaments that surround the. Tumori pre-maligne (precanceroase) Pre-malign înseamnă benign, dar care este posibil să se dezvolte în cancer dacă este lăsat netratat. Clasa tumorii premaligne este dificil de deosebit de celelalte două, deoarece se poate asemăna puternic cu o tumoră benignă în faza anterioară și mai târziu poate arăta mult mai mult ca o tumoră malignă Fertility-sparing surgery can effectively treat borderline ovarian tumors (BOTs), while preserving a woman's ability to conceive and bear children, a new study suggests.. The study, Reproductive and obstetrical outcomes with the overall survival of fertile-age women treated with fertility-sparing surgery for borderline ovarian tumors in Sweden: a prospective nationwide population-based.

Epitelni tumori jajnika | Poliklinika Harni

ConclusionsWomen diagnosed with at least borderline frozen section diagnoses were found to have a higher chance of carcinoma upon final diagnosis when compared with women with a straightforward borderline frozen section diagnosis (41.0% vs 9.7%). Especially in the serous subtype, and after preoperative consent, full staging during initial surgery might be considered in these cases to.. Borderline Resectable Pancreatic Cancer (BRPC) Pancreatic ductal adenocarcinoma (PDAC) is the third most common cause of cancer-related mortality in the United States with 41,780 projected deaths in 2016, and is expected to rise to the second leading cause by 2030 Borderline resectable per NCCN criteria (No distant metastases, venous involvement of the portal vein/SMV, demonstrating tumor abutment and narrowing of the lumen, encasement of the portal vein/SMV without encasement of the nearby arteries, or short-segment venous occlusion resulting from either tumor thrombus or encasement but with suitable.

Borderline Resectable Pancreatic Cancer (BRPC) Pancreatic ductal adenocarcinoma (PDAC) is the third most common cause of cancer-related mortality in the United States with 41,780 projected deaths in 2016, and is expected to rise to the second leading cause by 2030. This malignancy is characteristically highly aggressive and treatment-resistant. Fig. 2. Serous tumor of low malignant potential. The proliferating serous epithelium (arrow) shows stratification and tufting but lacks significant atypia and does not invade the underlying stroma. HE 20. - Paratubal borderline serous tumors Methods Our study group comprised 203 cases of serous borderline tumors sub-classified as atypical proliferative serous tumors or as non-invasive low-grade serous carcinomas. All pathological features related to borderline tumors were re-evaluated by two gynecological pathologists. Data concerning recurrences and survival were retrieved from the medical records of the patients

Biologically Borderline Tumors of the Lung and Pleura. The biologic difference between benign and borderline (very low-grade malignant) tumors is a subtle one because few of the latter neoplasms cause significant mortality. For this discussion, we have defined borderline lesions of the lung and pleura as those that have shown. Ovarian borderline mucinous cystadenoma. Dr Bahman Rasuli and Radswiki et al. Ovarian borderline mucinous cystadenomas are a subtype of ovarian mucinous tumors and, as the name stands, are intermediate between mucinous cystadenomas and mucinous cystadenocarcinomas. On this page

Vladimir DJORDJEVIC | General surgeon, Medical specialist

carcinoembryonic antigen (CEA)) and tumor size and histopathology in well staged patients with borderline ovarian tumors (BOTs). Methods. Four tumor markers (CA 125, CA 19-9, CA 15-3, and CEA) were analysed clinically in 60 well staged patients with borderline ovarian tumor, for this retrospective observational study. Results borderline resectable pancreatic cancer (BRPC) and locally advanced pancreatic cancer (LAPC). Converting patients from BRPC or LAPC to resectable status by means of ag-gressive neoadjuvant chemotherapy and/or radiation therapy (RT) is critical to improve outcomes for patients with non Results. In 371 patients who underwent surgery, R0 resection rates were 73% (171 of 235), 55% (57 of 104), and 16% (five of 32) for resectable, borderline resectable, and unresectable disease, respectively (P < .001).At multivariable analysis, tumor diameter larger than 4 cm (P < .001) and abutment to the portomesenteric vein (P < .001) were significantly associated with margin-positive. CASE REPORT General Urology doi: 10.4274/jus.2015.97 Journal of Urological Surgery, 2015; 2: 94-96 Cases of a Borderline Pathology That Can Mimic Bladder Cancer: Primary Amyloidosis of Urinary Bladder Mesane Kanserini Taklit Edebilen Farklı Bir Patoloji: Mesanenin Primer Amiloidozu Cemal Selçuk İşoğlu, Hakan Türk, Mustafa Karabıçak, Orçun Çelik, Hüseyin Tarhan, Ferruh Zorlu Tepecik. Borderline Brenner tumor Pattern of proliferating Brenner tumor with greater atypia (equivalent to grade I or II transitional cell carcinoma). Stromal invasion cannot be demonstrated Borderline Brenner tumor showing solid area with papillary formations, associated with a large cystic space Dr Aksharaditya Shukla 64